Osteoporosis in Children With ALL
NCT00330538 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2007-04-06
Summary
Hypothesis:
Pediatric patients with acute lymphoblastic leukemia, treated with chronic glucocorticoids as a part of the leukemia treatment protocol, will have an increased incidence and severity of osteoporosis.
Conditions
- Leukemia, Lymphocytic, Acute, L1
Sponsors & Collaborators
-
Children's Mercy Hospital Kansas City
lead OTHER
Principal Investigators
-
Jadranka Popovic, MD · Children's Mercy Hospital Kansas City
Eligibility
- Min Age
- 4 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-03-31
- Completion
- 2006-10-31
Countries
- United States
Study Locations
More Related Trials
-
Alendronate Osteoporosis Study
NCT00277251 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Zoledronic Acid in Osteoporosis of Children With Multiple Disabilities
NCT03301285 ·Status: COMPLETED
-
A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED)
NCT00480766 ·Status: COMPLETED ·Phase: PHASE3
-
Network Osteoporosis Study
NCT00209469 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis
NCT00259857 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Steroid-Induced Osteoporosis in Children
NCT00022841 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
NCT00049452 ·Status: COMPLETED ·Phase: PHASE3
-
Alendronate in Juvenile Osteoporosis
NCT00920075 ·Status: COMPLETED
-
Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
NCT00436917 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis
NCT00100620 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids
NCT03197623 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis
NCT00010439 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Childhood Osteoporosis With Alendronate (Fosamax)
NCT00001720 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss
NCT00333229 ·Status: TERMINATED ·Phase: PHASE4
-
The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.
NCT00346190 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis
NCT00051558 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis
NCT03164928 ·Status: COMPLETED ·Phase: PHASE3
-
Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta
NCT00131118 ·Status: COMPLETED ·Phase: PHASE2
-
Bone Effects of Teriparatide Following Alendronate
NCT00191893 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Odanacatib When Administered to Adolescents and Young Adults Treated With Glucocorticoids (MK-0822-066)
NCT01630616 ·Status: TERMINATED ·Phase: PHASE1
-
Osteoporosis Treatment Protocol in Patients With Fragility Fractures: Application and Efficacy
NCT04861142 ·Status: UNKNOWN
-
Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
NCT00000430 ·Status: TERMINATED ·Phase: PHASE3
-
Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women
NCT00504166 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy
NCT00616694 ·Status: COMPLETED ·Phase: PHASE4
-
Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation
NCT07245381 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2